While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every size
However, four injectable GLP-1 drugs, Saxenda (liraglutide), Wegovy (semaglutide), Bydureon BCISE (exenatide), and Trulicity (dulaglutide), have been approved for use in younger age groups
Depression A 2018 meta-analysis identified 12 randomized controlled trials, including 791 participants, that examined the effect of ALCAR on symptoms of depression (95)
(PubMed) Kook SY, Lee KM, Kim Y, et al
215,216 The GIP/GLP-1 receptor agonists have an additional agonism effect at the GIP receptor, resulting in increased insulin secretion in a glucose dependent manner and combined effects on appetite regulation and weight loss